中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01763 中国同辐

已收盘 05-14 16:09:12

18.980

-0.010

-0.05%

最高19.100	最低18.700	成交量15.22万
今开18.850	昨收18.990	日振幅2.11%
总市值60.74亿	流通市值15.18亿	总股本3.20亿
成交额288.14万	换手率0.19%	流通股本7,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":18.98,"timestamp":1778746152102,"preClose":18.99,"halted":0,"volume":152200,"delay":0,"changeRate":-0.0005265929436544504,"floatShares":79968800,"shares":320000000,"eps":1.1777214158709768,"marketStatus":"已收盘","change":-0.01,"latestTime":"05-14 16:09:12","open":18.85,"high":19.1,"low":18.7,"amount":2881420,"amplitude":0.021064,"askPrice":19.02,"askSize":200,"bidPrice":18.98,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":1.1777214158709768,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778808600000},"marketStatusCode":5,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":18.99,"dividendRate":0.018424,"openAndCloseTimeList":[[1778722200000,1778731200000],[1778734800000,1778745600000]],"volumeRatio":1.485168,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2633045088","title":"中国同辐(01763)附属公司中核高通及中国中原与邦德波尔签署《泰国次级标准化中子剂量实验室项目技术服务合同》","url":"https://stock-news.laohu8.com/highlight/detail?id=2633045088","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633045088?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:44","pubTimestamp":1778251440,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，中国同辐附属公司成都中核高通同位素股份有限公司及中国中原对外工程有限公司与邦德波尔分析有限公司签署《泰国次级标准化中子剂量实验室项目技术服务合同》。在本项目下，中核高通主要负责向邦德波尔提供所需产品及相关服务，中国中原则主要承担项目管理及监督职能，且不参与相关产品及服务的提供。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1244550577.SGD","BK4598","LU1244550494.USD","IE00BVYPNQ40.USD","BK4612","LU0079474960.USD","01763","BK4581","GB00BDT5M118.USD","BK4515","LU1069344957.HKD","SG9999015945.SGD","QCMU","BK4561","IE00BVYPNP33.GBP","BK1222","SG9999002224.SGD","LU0868494708.USD","LU1823568750.SGD","LU0868494617.USD","LU0061475181.USD","BK4585","BK4141","BK4532","IE00BGHQDM52.EUR","SG9999002232.USD","BK4527","SG9999015952.SGD","SG9999015978.USD","LU1084165304.USD","BK4605","BK4575","BK4573","LU2023250504.SGD","QCML","LU1496350502.SGD","SG9999001424.SGD","LU2247934214.USD","BK4554","LU1244550221.USD","LU1046421795.USD","BK4534","IE00BSNM7G36.USD","LU0942090050.USD","LU1119994496.HKD","LU1917777945.USD","BK4588","LU1974910355.USD","LU2106854487.HKD","LU0081259029.USD","BK4579","SG9999015986.USD","BK4604","BK4512","QCMD","LU1261432733.SGD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102556769","title":"中国同辐与中国核工业集团同Pondpol签署中子剂量学实验室项目合同","url":"https://stock-news.laohu8.com/highlight/detail?id=1102556769","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102556769?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:40","pubTimestamp":1778251213,"startTime":"0","endTime":"0","summary":"中国同辐（CIRC）与中国核工业集团已同Pondpol公司签署协议，共同承建中子剂量学实验室项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179499891","title":"中国同辐2026年4月股份变动月报：股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1179499891","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179499891?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:42","pubTimestamp":1777970541,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年5月5日发布截至2026年4月30日止的证券变动月报表。报告显示，公司期内各类股份未发生新增发行、购回或注销，股本保持稳定。截至报告期末，公司确认其股本结构稳健，遵循相关法律法规及香港联合交易所有限公司《上市规则》的规定。本次公告由联席公司秘书王仓忍签署。公司强调，其所有证券发行与股份变动事宜均严格遵守上市规范，并获得董事会正式授权批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8d4c202617d87be1d9fe31f833a300a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120925709","title":"中国同辐2025年收入同比微降 核医学与辐照业务多点推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1120925709","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120925709?lang=zh_cn&edition=full","pubTime":"2026-04-22 06:46","pubTimestamp":1776811601,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司在2025年度深耕核技术应用与同位素产业链，实现全年营业收入人民币71.88亿元，同比下降5.1%，主要受大型器械集采延缓及核医疗设备收入回落等因素影响。合并口径下利润总额为人民币10.04亿元，同比下降3.9%；年内净利润为人民币6.65亿元，同比下降24.4%。其中，归属于公司股东的净利润为人民币3.27亿元，同比下降19.5%，母公司财务口径下净利润为人民币4.574亿元，同比下降12.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中国同辐2025年收入同比微降 核医学与辐照业务多点推进","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153919300","title":"异动解读 | 中国同辐发布强劲2025年业绩，盘中大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153919300","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153919300?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:33","pubTimestamp":1774834394,"startTime":"0","endTime":"0","summary":"中国同辐今日盘中股价大幅上涨6.45%，市场表现活跃。消息面上，公司于盘前发布了2025年度业绩报告，多项财务指标表现亮眼。报告显示，公司整体毛利率提升至50.4%，创下新高；扣除一次性补税影响后，归母净利润同比增长12.5%。此外，放射源业务收入同比增长12.4%，出口收入同比大幅增长59.4%，展现出强劲的增长动力。公司还宣布派发现金股息，持续回报股东。这份强劲的业绩报告和积极的未来展望，显著提振了市场信心，成为推动股价上涨的主要因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623361201","title":"中国同辐2025毛利率提至50.4%创新高，“十五五”良好开局蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2623361201","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623361201?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:04","pubTimestamp":1774832664,"startTime":"0","endTime":"0","summary":"受子公司一次性补缴税费及滞纳金影响，报告期归属母公司净利润3.27亿元；扣除补税影响后，归母净利润4.57亿元，同比增长12.5%。公司整体毛利率提升至50.4%，同比提高1.8个百分点；营业成本同比下降8.4%，主要系呼吸检测产品原料实现国产化替代，销售费用同比下降10.7%，盈利质量与经营效率显著优化。2025年度拟共宣派现金股息每股0.3071元，合计约9823万元，持续回报股东。放射源业务实现收入8.1亿元，同比增长12.4%，毛利率大幅提升至50.25%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977612","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622871362","title":"中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622871362","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622871362?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:55","pubTimestamp":1774630556,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司的附属公司原子高科预计截至2025年12月31日止年度归属于挂牌公司股东的净利润为2.59亿元，相比上年同期减少3749.39万元，降幅12.65%。变动原因主要是受参股公司深圳市中核海得威生物科技有限公司归母净利润减少影响，公司本年度投资收益同比下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622879796","title":"中国同辐(01763)发布年度业绩，归母净利润3.27亿元 同比下降19.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622879796","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622879796?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:42","pubTimestamp":1774629772,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布截至2025年12月31日止年度业绩，该集团取得收益人民币71.88亿元(单位下同)，同比减少5.11%;公司权益股东应占利润3.27亿元，同比减少19.48%;每股盈利1.02元，拟派发末期现金股息每股0.2264元。公告称，营业收入下降主要受甲类大型医疗装备集采延迟导致核医疗装备收入下降影响。净利润6.645亿元，同比下降24.4%，归母净利润3.27亿元，同比下降19.5%。扣除附属公司补缴税费及滞纳金影响，归母净利润4.57亿元，同比增长12.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620223267","title":"中国同辐(01763)：签订股权转让协议 进一步拓展无损检测业务版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2620223267","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620223267?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:04","pubTimestamp":1773925467,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，3月19日，中国同辐附属公司成都中核高通同位素股份有限公司签署《股权转让协议》，收购湖南汇丰工程检测有限公司51%股权。中核高通在国内无损检测放射源市场占据主导地位，拥有绝大多数市场份额。本次交易是中核高通自2023年收购西安展实检测工程有限公司以来的又一次无损检测业务版图拓展，将助力其进一步扩大细分领域市场份额，增强综合竞争实力，稳步提升行业市场地位与核心影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142798963","title":"中国同辐子公司达成协议 收购湖南汇丰工程检测51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1142798963","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142798963?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:00","pubTimestamp":1773925227,"startTime":"0","endTime":"0","summary":"中国同辐旗下子公司签署协议，将收购湖南汇丰工程检测有限公司51%股权。此次股权收购标志着中国同辐在检测服务领域的战略布局取得新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619136191","title":"中国同辐(01763)及附属公司中核海得威与茂名市人民政府签署《战略合作协议》 共同推动核技术应用产业在粤西地区的集聚与落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2619136191","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619136191?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:12","pubTimestamp":1773411143,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，3月13日，中国同辐及附属公司中核海得威与广东省茂名市人民政府签署《战略合作协议》。根据《战略合作协议》，三方确立为全面战略合作伙伴关系，共同推动核技术应用产业在粤西地区的集聚与落地，将茂名打造成为华南地区重要的稳定同位素研发生产基地及核医学应用示范区。三方将充分利用自身优势，聚焦稳定同位素关键技术攻关，提升我国核技术应用产业链的韧性、安全性和保障能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617848586","title":"中国同辐03月06日主力净流出124.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2617848586","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617848586?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784908,"startTime":"0","endTime":"0","summary":"03月06日, 中国同辐股价跌1.07%，报收20.40元，成交金额422.4万元，换手率0.26%，振幅1.84%，量比0.78。中国同辐今日主力资金净流出124.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.45%，主力资金累计净流出179.9万元；近20日主力资金累计净流出477.3万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161518a453470e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161518a453470e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616300456","title":"中国同辐03月03日主力净流出117.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616300456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616300456?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:16","pubTimestamp":1772525766,"startTime":"0","endTime":"0","summary":"03月03日, 中国同辐股价跌1.04%，报收20.90元，成交金额634.9万元，换手率0.38%，振幅3.03%，量比1.81。中国同辐今日主力资金净流出117.1万元，上一交易日主力净流入147.4万元。该股近5个交易日上涨0.29%，主力资金累计净流入28.0万元；近20日主力资金累计净流出229.3万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162216a69c9d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162216a69c9d5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616833339","title":"中国同辐(01763)：自主研发的“红细胞寿命测定呼气分析仪”获得第二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616833339","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616833339?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:33","pubTimestamp":1772447586,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，中国同辐附属公司中核海得威所属安徽养和医疗器械设备有限公司自主研发的“红细胞寿命测定呼气分析仪”获得第二类医疗器械注册证，该设备获批上市。检测红细胞寿命可以明确病因。红细胞寿命测定能帮助医生快速判断。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01763","09997","09996","159883","BK1222","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143771802","title":"中国同辐（01763）更新2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143771802","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143771802?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:43","pubTimestamp":1772440981,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年3月2日发布截至2026年2月28日的月度证券变动报告。报告显示，公司H股及内资股在当月均无新增发行、购回或注销活动，股本结构保持稳定。\n公告披露，公司于本月底H股已发行数量为79,968,800股，内资股已发行数量为239,906,100股，两类股份均无变动。截至2026年2月底，公司注册股本总数为319,874,900股，较上月无任何增减。\n根据公告，公司确认遵守香港联合交易所有限公司证券上市规则及其他相关监管法规，所有必要文件均已递交。公告由联席公司秘书王仓忍签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613521256","title":"附属公司补缴税款及滞纳金2.7亿元“吞噬”利润！中国同辐去年业绩预减，核医疗装备收益下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2613521256","media":"深圳商报·读创","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613521256?lang=zh_cn&edition=full","pubTime":"2026-02-21 13:56","pubTimestamp":1771653403,"startTime":"0","endTime":"0","summary":"附属公司补缴税款及滞纳金2.7亿元“吞噬”利润！中国同辐去年业绩预减，核医疗装备收益下降","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602213651789152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763","159891","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611135561","title":"中国同辐盈警后一度跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611135561","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611135561?lang=zh_cn&edition=full","pubTime":"2026-02-13 15:00","pubTimestamp":1770966050,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月13日，中国同辐(01763.HK)盈警后一度跌超7%，截至发稿跌6.54%，报20.3港元，成交额1147.11万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602133650351990.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"e72ce594d163813446b6a4d8cf9cfd10","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602133650351990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610445939","title":"中国同辐：2025年归母净利润预降约20%至25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610445939","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610445939?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:10","pubTimestamp":1770891010,"startTime":"0","endTime":"0","summary":"2月12日，中国同辐（01763）发布公告，公司预计2025年收益约69.79亿元至72.06亿元，同比下降约5%至8%；净利润预计为6.11亿元至6.55亿元，同比下降约25%至30%；归母净利润约3.02亿元至3.22亿元，同比下降约20%至25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602123649342238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611042649","title":"中国同辐：预计2025年度净利润6.11亿元至6.55亿元 同比减少约25...","url":"https://stock-news.laohu8.com/highlight/detail?id=2611042649","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611042649?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:58","pubTimestamp":1770890280,"startTime":"0","endTime":"0","summary":"截至目前，公司经营运作正常，2025年度收益减少主要由于集团的核医疗装备分部收益下降，利润减少主要由于公司附属公司深圳市中核海得威生物科技有限公司补缴税费及滞纳金影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212180038a6f2e554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212180038a6f2e554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107743382","title":"中国同辐股份有限公司2025年度营收约人民币69.79亿元至72.06亿元，净利润约人民币3.02亿元至3.22亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107743382","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107743382?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:52","pubTimestamp":1770889934,"startTime":"0","endTime":"0","summary":"本季度信息\n根据公告，中国同辐股份有限公司预计，截至2025年12月31日止年度，营收约人民币69.79亿元至人民币72.06亿元，同比减少约5%至8%；净利润约人民币3.02亿元至人民币3.22亿元，同比减少约20%至25%。\n公司表示，目前经营运作正常。营业收入下滑主要来自核医疗装备业务板块的收益下降；净利润减少则受到旗下深圳市中核海得威生物科技有限公司补缴税费及滞纳金的影响。\n业务分项\n公告显示，核医疗装备分部营收出现下滑，进一步拖累了整体营收表现。该分部业绩下降与市场环境及补缴税费事项共同影响了公司整体利润水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0037},{"period":"3month","weight":-0.1257},{"period":"6month","weight":-0.1878},{"period":"1year","weight":0.6942},{"period":"ytd","weight":-0.0599}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0284},{"period":"3month","weight":-0.0238},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1419},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.035423},{"month":2,"riseRate":0.5,"avgChangeRate":0.038793},{"month":3,"riseRate":0.375,"avgChangeRate":-0.034585},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018496},{"month":5,"riseRate":0.625,"avgChangeRate":0.014582},{"month":6,"riseRate":0.571429,"avgChangeRate":0.05564},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.022851},{"month":8,"riseRate":0.5,"avgChangeRate":0.038573},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029064},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037438},{"month":11,"riseRate":0.75,"avgChangeRate":0.064344},{"month":12,"riseRate":0.5,"avgChangeRate":0.001691}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}